Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By Political Calculations (Reporter)
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

S&P 500 Rises as Beaten Down Big-Tech Stocks Roar Back

% of readers think this story is Fact. Add your two cents.


An editorial cartoon of a Wall Street bull who is happy because stock prices are rising, with a rising stock chart in the background. Image generated with Microsoft Copilot Designer.

The S&P 500 (Index: SPX) had its best week to date in 2025, rising 4.6% to close out the trading week ending on Friday, 25 April 2025 at 5,525.21.

It was an especially good week for the index’ mega-cap Big-Tech stocks, with much of the increase of the index driven by their outsized concentration within it. Here’s a quick summary of how much the share prices of the S&P 500′s Top 10 stocks changed over the preceding week:

  • Apple (NASDAQ: AAPL) $209.28 (+7.8%)
  • Microsoft (NASDAQ: MSFT) $391.85 (+7.9%)
  • Nvidia (NASDAQ: NVDA) $111.01 (+13.4%)
  • Amazon (NASDAQ: AMZN) $188.99 (+12.2%)
  • Meta Platforms (A) (NASDAQ: META) $547.27 (+11.8%)
  • Berkshire Hathaway (B) (NYSE: BRK.B) $530.96 (+2.4%)
  • Alphabet (A) (NASDAQ: GOOGL) $161.96 (+9.1%)
  • Broadcom (NASDAQ: AVGO) $192.31 (+14.8%)
  • Alphabet (C) (NASDAQ: GOOG) $163.85 (+8.8%)
  • Tesla (NASDAQ: TSLA) $284.95 (+24.2%)

One of these stocks is not like the others, as Berkshire Hathaway is not a member of the mega-cap Big-Tech club, which makes it a representative of what the stocks of the rest of the index experienced on average during the week. As for the mega-cap Big Tech club, most of these stocks have been hammered during the year-to-date going into the week, with many having been taken down with the deflation of the AI bubble after the 21 February 2025 announcement the code behind China’s DeepSeek artificial intelligence system would be made open source.

The change in fortune for these firms is such we may need to consider whether another new market regime is taking shape. The current market regime took hold after 21 February 2025, which is something we’ll be evaluating behind the scenes for the dividend futures-based model over the next weeks. We’ll also be weighing whether investors have shifted their forward-looking focus from the current quarter of 2025-Q4 toward the more distant investment horizon of 2025-Q4.

Speaking of the dividend futures-based model, here’s the latest update of the alternative futures charts. We find the trajectory of the S&P 500 has soared above the redzone forecast range, which we’ve extended two weeks longer to account for the ongoing high volatility of stock prices.

Alternative Futures - S&P 500 - 2025Q2 - Standard Model (m=+4.0 from 24 February 2025) - Snapshot on 25 Apr 2025

We’re considering the potential of an outward shift in the time horizon of investors because earnings season is now underway, in which companies are projecting their outlooks through the end of the current year, and because of recent changes in investor expectations of rate cuts during 2025-Q4.

On that count, the CME Group’s FedWatch Tool projects the Fed will still hold off in resuming its cuts of the Federal Funds Rate until the conclusion of its 18 June (2025-Q2) meeting, at which time it will reduce this interest rate by 0.25%. Afterward, the FedWatch Tool forecasts the Fed will reduce U.S. interest rates three more times before the end of 2025, which is a development that’s taken place during the last two weeks. The FedWatch Tool foresees 0.25% cuts in the Federal Funds Rate on 30 July (2025-Q3), 29 October (2025-Q4), and 10 December (2025-Q4).

Here are the market-moving headlines that informed investor expectations during the past week.

Monday, 21 April 2025
  • Signs and portents for the U.S. economy:
  • Oil falls over 2% on signs of progress in US-Iran talks, demand fears
  • Fed minions say persistent Bidenflation keeping them from cutting U.S. interest rates:
  • Bigger trouble developing in China after pre-tariff export push:
  • BOJ minions say they’ll keep hiking Japan’s interest rates if inflation remains on track, but core inflation picks up speed:
  • ECB minion says U.S. chief Fed minion is their idea of an “exemplary” central banker:
  • Nasdaq, S&P, and Dow finished sharply lower as Trump feuds with Powell
  • Tuesday, 22 April 2025
    • Signs and portents for the U.S. economy:
  • Chief Fed minion’s job appears safe… for now:
  • Fed minions stay noncommittal on when they’ll resume rate cuts, think US poverty levels understated in recent years:
  • BOJ minions act like they will try to keep plan to hike Japan’s interest rates alive:
  • ECB minions claim they’re close to hitting inflation target and that Eurozone economy was looking good before US tariffs:
  • Euro zone firms were seeing improved business momentum before tariffs, ECB says
  • Nasdaq, S&P, and Dow rallied higher a day after markets observed a large sell-off
  • Wednesday, 23 April 2025
    • Signs and portents for the U.S. economy:
  • US PMIs Scream Stagflation As Manufacturing ‘Contracts’, Prices Rise, Heaviest Job Cuts Since GFC
  • US new home sales jump in March; supply still rising
  • Donald Trump to exempt carmakers from some US tariffs
  • Fed minions say they’ll hold the Federal Funds Rate where it is for longer, plan to keep keep letting maturing U.S. Treasuries drop off their books:
  • Bigger bailouts, trouble, stimulus developing in China:
  • IMF minions don’t think BOJ minions will follow through on plan to hike Japan’s interest rates:
  • ECB minions think Eurozone inflation will keep falling as Eurozone economy keeps flailing:
  • European business growth stalls in April, PMIs show
  • Wall Street ends off session high, but rally extends with Nasdaq up 2.5%, S&P up about 2%
  • Thursday, 24 April 2025
    • Signs and portents for the U.S. economy:
  • Fed minions get mixed picture of economy:
  • Bigger trouble, anemic stimulus developing in China:
  • ECB minions getting excited for their next Eurozone interest rate cut, starting to think about moving faster on their next moves:
  • ECB eyeing more nimble policy moves amid price shocks, Bloomberg News reports
  • Nasdaq rises nearly 3%, S&P adds 2% as Wall Street posts three-day win streak
  • Friday, 25 April 2025
    • Signs and portents for the U.S. economy:
  • Trump says China’s Xi has called him and that US and China are in trade talks, Time reports
  • Fed minions say they’ll be patient before doing anything about tariff impact to economy, receive criticism from former minion:
  • Some tariff relief for US goods developing in China:
  • Wall Street’s four-day rally takes it to a nearly 5% weekly advance
  • Wall Street ends with weekly gains as trade negotiations, earnings in focus
  • Analysts praise Alphabet after results amaze Wall Street
  • The raw Atlanta Fed’s GDPNow tool‘s projection of what real GDP growth will be in 2025-Q1 dipped to -2.5% from its -2.2% estimate a week earlier, which is misleading. The GDPNow tool’s alternate model forecast, which corrects for an extraordinary surge in gold imports during the quarter that’s badly skewing the GDPNow tool’s raw projection, declined from an estimate of -0.1% growth to -0.4% growth, meaning the real economy likely shrank by a small percentage during the first quarter.

    That’s not unexpected as a recession forecasting model based on the level of the Federal Funds Rate and the U.S. Treasury yield curve signaled a recession was likely to start during this period more than a year ago. We should get the BEA’s first estimate of GDP during 2025-Q1 this week, while the GDPNow tool will reset its focus to the now-current quarter of 2025-Q2.

    Image credit: Microsoft Copilot Designer. Prompt: “An editorial cartoon of a Wall Street bull who is happy because stock prices are rising, with a rising stock chart in the background”.



    Source: https://politicalcalculations.blogspot.com/2025/04/s-500-rises-as-beaten-down-big-tech.html


    Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

    Anyone can join.
    Anyone can contribute.
    Anyone can become informed about their world.

    "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

    Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.


    LION'S MANE PRODUCT


    Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules


    Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.



    Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.


    Report abuse

    Comments

    Your Comments
    Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

    MOST RECENT
    Load more ...

    SignUp

    Login

    Newsletter

    Email this story
    Email this story

    If you really want to ban this commenter, please write down the reason:

    If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.